9323a18d2a97d55242530f345722a876 leukemia_a2017v31p107iENG.pdf 2c4ff7d31a30f0d330daaacde0c993ad8c655611 leukemia_a2017v31p107iENG.pdf 950685863d817cd875863457162ddf4f92bc25c3df86ebf5632fcd85b05dfe3a leukemia_a2017v31p107iENG.pdf Title: A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS) Subject: Leukemia 31, 107 (2017). doi:10.1038/leu.2016.176 Author: R Hájek Creator: Arbortext Advanced Print Publisher 10.0.1465/W Unicode Producer: Acrobat Distiller 8.1.0 (Windows) CreationDate: Thu Nov 24 23:51:15 2016 CET ModDate: Fri Dec 9 12:48:33 2016 CET Tagged: no UserProperties: no Suspects: no Form: AcroForm JavaScript: no Pages: 8 Encrypted: no Page size: 595.276 x 790.866 pts Page rot: 0 File size: 807639 bytes Optimized: yes PDF version: 1.6 name type encoding emb sub uni object ID ------------------------------------ ----------------- ---------------- --- --- --- --------- FONCJL+AdvOT3b30f6db.B Type 1C WinAnsi yes yes no 237 0 FONCKL+AdvEls-ent4 Type 1C WinAnsi yes yes no 248 0 FONCLM+AdvOT46dcae81+01 Type 1C Custom yes yes yes 251 0 FONCGB+Arial-BoldMT Type 1C WinAnsi yes yes no 212 0 FONCHC+AdvTT5afe5d37.B Type 1C WinAnsi yes yes no 213 0 FONCIC+AdvOTa20b42a7 Type 1C WinAnsi yes yes no 214 0 FONCID+AdvOTa20b42a7+fb Type 1C Custom yes yes yes 211 0 FONCIE+AdvTT6780a46b Type 1C WinAnsi yes yes no 215 0 FONCIF+AdvTT6780a46b+fb Type 1C Custom yes yes yes 226 0 FONCIG+AdvOT46dcae81 Type 1C WinAnsi yes yes no 227 0 FONCJH+AdvOT46dcae81+fb Type 1C Custom yes yes yes 228 0 FONCJI+AdvOT65f8a23b.I Type 1C WinAnsi yes yes no 245 0 FONCJJ+AdvOT46dcae81+20 Type 1C WinAnsi yes yes no 235 0 FONCJK+AdvOT8608a8d1+2a Type 1C Custom yes yes yes 236 0 FONCMN+AdvPi1 Type 1C WinAnsi yes yes no 75 0 FONCMO+AdvOT46dcae81+03 Type 1C Custom yes yes yes 73 0 FPDFEI+AdvOT919a0533.B Type 1C WinAnsi yes yes no 72 0 FPDKFI+AdvOT7d2ebc01 Type 1C WinAnsi yes yes no 70 0 FPEABE+AdvOT65f8a23b.I+fb Type 1C Custom yes yes yes 89 0 FPEABF+AdvTT6780a46b+20 Type 1C WinAnsi yes yes no 83 0 FPEABG+AdvOT8608a8d1+03 Type 1C Custom yes yes yes 81 0 FPEACG+AdvTT6780a46b+22 Type 1C Custom yes yes no 85 0 FPEALE+ArialMT Type 1C WinAnsi yes yes no 90 0 FPEBAD+AdvOT8608a8d1 Type 1C WinAnsi yes yes no 91 0 Jhove (Rel. 1.6, 2011-01-04) Date: 2018-12-15 04:47:57 CET RepresentationInformation: leukemia_a2017v31p107iENG.pdf ReportingModule: PDF-hul, Rel. 1.8 (2009-05-22) LastModified: 2018-10-04 17:11:31 CEST Size: 807639 Format: PDF Version: 1.6 Status: Well-Formed, but not valid SignatureMatches: PDF-hul ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 ErrorMessage: Invalid destination object Offset: 792952 MIMEtype: application/pdf Profile: Linearized PDF PDFMetadata: Objects: 278 FreeObjects: 1 IncrementalUpdates: 1 DocumentCatalog: PageLayout: SinglePage PageMode: UseNone Outlines: Item: Title: Introduction Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@7c53a9eb Children: Item: Title: Introduction Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@ed17bee Item: Title: Methods Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@2a33fae0 Children: Item: Title: Participants Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@707f7052 Item: Title: Procedures Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@11028347 Item: Title: Figure 1 Random assignment and follow-up. Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@14899482 Children: Item: Title: Objectives Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@21588809 Item: Title: Assessments Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@2aae9190 Item: Title: Statistical analyses Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@2f333739 Item: Title: Table 1 Baseline patient and disease characteristics Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@77468bd9 Children: Item: Title: Changes in methods after trial commencement Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@12bb4df8 Item: Title: Results Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4cc77c2e Children: Item: Title: Patients and enrollment Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@7a7b0070 Item: Title: Efficacy Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@39a054a5 Item: Title: Table 2 Prior regimens received by patients Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@71bc1ae4 Item: Title: Figure 2 Kaplan€−€Meier estimates of (a) OS and (b)’PFS. Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@6ed3ef1 Children: Item: Title: Safety Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@2437c6dc Item: Title: Discussion Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@1f89ab83 Item: Title: Table 3 Efficacy results Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@e73f9ac Item: Title: Table 3 Efficacy results Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@61064425 Item: Title: Table 3 Efficacy results Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@7b1d7fff Item: Title: ACKNOWLEDGEMENTS Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@299a06ac Item: Title: Table 4 Hematologic and nonhematologic adverse eventsa Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@383534aa Item: Title: REFERENCES Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@6bc168e5 Info: Title: A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS) Author: R Hájek Subject: Leukemia 31, 107 (2017). doi:10.1038/leu.2016.176 Creator: Arbortext Advanced Print Publisher 10.0.1465/W Unicode Producer: Acrobat Distiller 8.1.0 (Windows) CreationDate: Thu Nov 24 23:51:15 CET 2016 ModDate: Fri Dec 09 13:18:33 CET 2016 ID: 0x0bd78e6abbf254f0b5a3ba158804a087, 0x0b21167d9164ba4d8283a4effd7ad7da Filters: FilterPipeline: FlateDecode FilterPipeline: DCTDecode Images: Image: NisoImageMetadata: CompressionScheme: JPEG ImageWidth: 4000 ImageHeight: 3776 BitsPerSample: 8 BitsPerSampleUnit: integer Fonts: Type1: Font: BaseFont: FONCIF+AdvTT6780a46b+fb FontSubset: true FirstChar: 1 LastChar: 3 FontDescriptor: FontName: FONCIF+AdvTT6780a46b+fb Flags: Symbolic FontBBox: 9, 0, 875, 750 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: FONCIG+AdvOT46dcae81 FontSubset: true FirstChar: 37 LastChar: 246 FontDescriptor: FontName: FONCIG+AdvOT46dcae81 Flags: Nonsymbolic FontBBox: -41, -250, 833, 875 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FONCJH+AdvOT46dcae81+fb FontSubset: true FirstChar: 1 LastChar: 3 FontDescriptor: FontName: FONCJH+AdvOT46dcae81+fb Flags: Symbolic FontBBox: 0, 0, 739, 718 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: FPDKFI+AdvOT7d2ebc01 FontSubset: true FirstChar: 48 LastChar: 57 FontDescriptor: FontName: FPDKFI+AdvOT7d2ebc01 Flags: Nonsymbolic FontBBox: -31, -208, 958, 916 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FPDFEI+AdvOT919a0533.B FontSubset: true FirstChar: 46 LastChar: 117 FontDescriptor: FontName: FPDFEI+AdvOT919a0533.B Flags: Nonsymbolic FontBBox: -31, -250, 656, 875 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FONCMO+AdvOT46dcae81+03 FontSubset: true FirstChar: 1 LastChar: 1 FontDescriptor: FontName: FONCMO+AdvOT46dcae81+03 Flags: Symbolic FontBBox: -31, -208, 739, 802 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: FONCJJ+AdvOT46dcae81+20 FontSubset: true FirstChar: 145 LastChar: 151 FontDescriptor: FontName: FONCJJ+AdvOT46dcae81+20 Flags: Nonsymbolic FontBBox: 0, -197, 1125, 864 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FONCMN+AdvPi1 FontSubset: true FirstChar: 52 LastChar: 52 FontDescriptor: FontName: FONCMN+AdvPi1 Flags: Nonsymbolic FontBBox: 13, -323, 958, 824 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FONCJK+AdvOT8608a8d1+2a FontSubset: true FirstChar: 1 LastChar: 1 FontDescriptor: FontName: FONCJK+AdvOT8608a8d1+2a Flags: Symbolic FontBBox: 0, -437, 1385, 937 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: FONCJL+AdvOT3b30f6db.B FontSubset: true FirstChar: 44 LastChar: 119 FontDescriptor: FontName: FONCJL+AdvOT3b30f6db.B Flags: Nonsymbolic FontBBox: -31, -250, 875, 895 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FPEABG+AdvOT8608a8d1+03 FontSubset: true FirstChar: 1 LastChar: 1 FontDescriptor: FontName: FPEABG+AdvOT8608a8d1+03 Flags: Symbolic FontBBox: -479, -364, 854, 927 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: FONCID+AdvOTa20b42a7+fb FontSubset: true FirstChar: 1 LastChar: 1 FontDescriptor: FontName: FONCID+AdvOTa20b42a7+fb Flags: Symbolic FontBBox: 0, 0, 531, 708 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: FPEABF+AdvTT6780a46b+20 FontSubset: true FirstChar: 146 LastChar: 150 FontDescriptor: FontName: FPEABF+AdvTT6780a46b+20 Flags: Nonsymbolic FontBBox: 0, -114, 1156, 750 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FONCGB+Arial-BoldMT FontSubset: true FirstChar: 69 LastChar: 80 FontDescriptor: FontName: FONCGB+Arial-BoldMT Flags: Nonsymbolic FontBBox: -628, -376, 2000, 1010 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FONCHC+AdvTT5afe5d37.B FontSubset: true FirstChar: 65 LastChar: 98 FontDescriptor: FontName: FONCHC+AdvTT5afe5d37.B Flags: Nonsymbolic FontBBox: -31, -250, 895, 864 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FONCJI+AdvOT65f8a23b.I FontSubset: true FirstChar: 37 LastChar: 122 FontDescriptor: FontName: FONCJI+AdvOT65f8a23b.I Flags: Nonsymbolic FontBBox: -104, -250, 885, 864 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FPEACG+AdvTT6780a46b+22 FontSubset: true FirstChar: 21 LastChar: 21 FontDescriptor: FontName: FPEACG+AdvTT6780a46b+22 Flags: Nonsymbolic FontBBox: 0, -250, 875, 791 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true Font: BaseFont: FONCIC+AdvOTa20b42a7 FontSubset: true FirstChar: 40 LastChar: 122 FontDescriptor: FontName: FONCIC+AdvOTa20b42a7 Flags: Serif, Nonsymbolic FontBBox: -72, -239, 979, 906 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FONCIE+AdvTT6780a46b FontSubset: true FirstChar: 37 LastChar: 243 FontDescriptor: FontName: FONCIE+AdvTT6780a46b Flags: Nonsymbolic FontBBox: -41, -250, 875, 843 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FONCKL+AdvEls-ent4 FontSubset: true FirstChar: 111 LastChar: 111 FontDescriptor: FontName: FONCKL+AdvEls-ent4 Flags: Nonsymbolic FontBBox: 0, -343, 1166, 1218 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FPEABE+AdvOT65f8a23b.I+fb FontSubset: true FirstChar: 1 LastChar: 1 FontDescriptor: FontName: FPEABE+AdvOT65f8a23b.I+fb Flags: Symbolic FontBBox: 0, 0, 781, 718 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: FPEALE+ArialMT FontSubset: true FirstChar: 32 LastChar: 150 FontDescriptor: FontName: FPEALE+ArialMT Flags: Nonsymbolic FontBBox: -2, -210, 827, 728 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: FONCLM+AdvOT46dcae81+01 FontSubset: true FirstChar: 1 LastChar: 151 FontDescriptor: FontName: FONCLM+AdvOT46dcae81+01 Flags: Symbolic FontBBox: -41, -218, 854, 864 FontFile3: true EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: FPEBAD+AdvOT8608a8d1 FontSubset: true FirstChar: 61 LastChar: 61 FontDescriptor: FontName: FPEBAD+AdvOT8608a8d1 Flags: Nonsymbolic FontBBox: -62, -208, 927, 958 FontFile3: true Encoding: WinAnsiEncoding XMP: application/pdf doi:10.1038/leu.2016.176 R Hájek T Masszi M T Petrucci A Palumbo L Rosiñol A Nagler K L Yong A Oriol J Minarik L Pour M A Dimopoulos V Maisnar D Rossi H Kasparu J Van Droogenbroeck D B Yehuda I Hardan M Jenner M Calbecka M Dávid J de la Rubia J Drach Z Gasztonyi S Górnik X Leleu M Munder M Offidani N Zojer K Rajangam Y-L Chang J F San-Miguel H Ludwig Leukemia 31, 107 (2017). doi:10.1038/leu.2016.176 Nature Publishing Group © 2017 The Author(s) A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS) Acrobat Distiller 8.1.0 (Windows) © 10.1038/leu.2016.176 1476-5551 114 0887-6924 1 permissions@nature.com 107 31 2016 2016-06 07-24 15 http://dx.doi.org/10.1038/leu.2016.176 2016-11-24T22:51:15Z Arbortext Advanced Print Publisher 10.0.1465/W Unicode Leukemia 31, 107 (2016 2016). doi:10.1038/leu.2016.176 2016-12-09T17:18:33+05:30 2016-12-09T17:18:33+05:30 doi:10.1038/leu.2016.176 True uuid:1f140a89-1536-4abf-99c3-ce9ad7504e27 uuid:f6b89faf-d2de-4327-b9bf-e5ce783703fa Pages: Page: Label: 1 Annotations: Annotation: Subtype: Link Rect: 177, 410, 256, 419 Annotation: Subtype: Link Rect: 257, 339, 260, 348 Destination: 59 Annotation: Subtype: Link Rect: 273, 318, 283, 327 Destination: 59 Annotation: Subtype: Link Rect: 239, 297, 242, 306 Destination: 59 Annotation: Subtype: Link Rect: 244, 297, 247, 306 Destination: 59 Annotation: Subtype: Link Rect: 248, 297, 251, 306 Destination: 59 Annotation: Subtype: Link Rect: 253, 297, 256, 306 Destination: 59 Annotation: Subtype: Link Rect: 280, 245, 283, 254 Destination: 59 Annotation: Subtype: Link Rect: 354, 373, 358, 382 Destination: 59 Annotation: Subtype: Link Rect: 359, 373, 363, 382 Destination: 59 Annotation: Subtype: Link Rect: 412, 341, 420, 350 Destination: null Annotation: Subtype: Link Rect: 346, 319, 364, 328 Destination: null Annotation: Subtype: Link Rect: 318, 214, 336, 223 Destination: null Annotation: Subtype: Link Rect: 57, 74, 115, 81 Annotation: Subtype: Link Rect: 278, 734, 351, 742 Thumb: true Page: Label: 2 Thumb: true Page: Label: 3 Annotations: Annotation: Subtype: Link Rect: 83, 486, 89, 494 Destination: null Annotation: Subtype: Link Rect: 249, 450, 255, 458 Destination: null Annotation: Subtype: Link Rect: 162, 77, 165, 85 Destination: 59 Annotation: Subtype: Link Rect: 166, 77, 169, 85 Destination: 59 Annotation: Subtype: Link Rect: 150, 59, 156, 67 Destination: null Thumb: true Page: Label: 4 Annotations: Annotation: Subtype: Link Rect: 258, 412, 289, 421 Destination: 1 Annotation: Subtype: Link Rect: 313, 570, 344, 579 Destination: 11 Annotation: Subtype: Link Rect: 370, 498, 397, 507 Destination: 23 Thumb: true Page: Label: 5 Annotations: Annotation: Subtype: Link Rect: 66, 597, 97, 606 Destination: 29 Annotation: Subtype: Link Rect: 84, 576, 111, 585 Destination: 42 Annotation: Subtype: Link Rect: 250, 545, 279, 554 Destination: 29 Annotation: Subtype: Link Rect: 445, 712, 472, 721 Destination: 42 Annotation: Subtype: Link Rect: 429, 587, 457, 596 Destination: 42 Thumb: true Page: Label: 6 Annotations: Annotation: Subtype: Link Rect: 105, 615, 136, 624 Destination: 49 Annotation: Subtype: Link Rect: 182, 491, 210, 500 Destination: 49 Thumb: true Page: Label: 7 Annotations: Annotation: Subtype: Link Rect: 277, 171, 283, 180 Destination: null Annotation: Subtype: Link Rect: 182, 151, 189, 160 Destination: null Annotation: Subtype: Link Rect: 477, 707, 484, 716 Destination: null Annotation: Subtype: Link Rect: 497, 518, 504, 527 Destination: null Annotation: Subtype: Link Rect: 517, 498, 524, 507 Destination: null Annotation: Subtype: Link Rect: 512, 458, 518, 467 Destination: null Annotation: Subtype: Link Rect: 456, 418, 463, 427 Destination: null Thumb: true Page: Label: 8 Annotations: Annotation: Subtype: Link Rect: 374, 481, 559, 488 Annotation: Subtype: Link Rect: 321, 472, 331, 479 Annotation: Subtype: Link Rect: 541, 338, 559, 345 Annotation: Subtype: Link Rect: 311, 329, 441, 336 Thumb: true Checksum: b56c5ffc Type: CRC32 Checksum: 9323a18d2a97d55242530f345722a876 Type: MD5 Checksum: 2c4ff7d31a30f0d330daaacde0c993ad8c655611 Type: SHA-1